Syrma SGS Q4 FY26 Results: Estimates and Dividend Watch

What is scheduled for May 2026

Syrma SGS Technology (NSE: SYRMA) is preparing to announce its Q4 FY26 financial results for the quarter ended March 31, 2026. The company’s board of directors is expected to meet in May 2026 to approve the audited financial statements. The same meeting is also expected to consider a final dividend recommendation. For investors, this is a key event because Q4 typically finalises the full-year FY26 picture and sets the baseline for FY27 expectations. The electronics manufacturing services (EMS) space also tends to react sharply to margin commentary and order-mix updates. Syrma SGS is part of a segment where operating leverage and product mix can move profitability more than headline revenue.

Street expectations: revenue, PAT and EBITDA margin

Analyst estimates for Q4 FY26 revenue stand in the range of ₹1,150-1,260 crore. Profit after tax (PAT) expectations are ₹38-48 crore. EBITDA margin projections are at 6.5-7.5%, as per estimates cited in the provided context. Syrma SGS enters the quarter with expectations of 15-20% year-on-year revenue growth. While these are estimates, the results will be read in the context of whether margin delivery matches the mix shift the company has discussed in past quarters. Investors will also look at whether profitability is broad-based or concentrated in a few segments.

Why Q4 FY26 matters more than a single quarter

Q4 results will also determine full-year FY26 performance in market models and broker spreadsheets. That matters because FY27 numbers are often built by applying growth and margin assumptions to FY26 audited figures. Another reason the quarter is watched closely is the final dividend decision, which can signal management’s comfort on cash generation and capital allocation. In this case, the expectation mentioned is that the final dividend could be nil. Even without a payout, commentary around cash flows, working capital and expansion priorities tends to shape how the stock is valued.

PAT quality: operational gains vs one-offs

The estimated PAT range of ₹38-48 crore is likely to be dissected beyond the absolute number. Investors will assess whether PAT is driven by operational improvement or non-recurring items. In EMS businesses, quarterly profitability can be influenced by product mix, client schedule phasing, export orders, and overhead absorption. Any mention of one-time incentives, exceptional income or cost reversals could change how the market views the sustainability of margins. The focus is usually on what part of profit is repeatable and linked to core execution.

Dividend expectations: nil, and what it signals

Syrma SGS Technology is expected to consider a final dividend, with “nil expected” stated in the context provided. Dividend decisions in this sector are often weighed against growth investments and working capital needs. A nil dividend does not automatically imply weaker fundamentals, but it can indicate a preference to retain cash for operations or expansion. It also sets expectations for FY27 capital allocation priorities, especially if the company continues shifting toward higher value segments. The board’s discussion and any rationale shared with investors will be closely tracked.

Stock context: where SYRMA is trading

Syrma SGS Technology is trading at ₹560, as per the data provided. The stock’s 52-week high is ₹820 and the 52-week low is ₹450. These levels matter because investor reactions to results are often anchored to recent ranges and expectations already priced in. If results land inside the estimate band, management commentary tends to drive direction more than the headline numbers. If results fall outside the range, the move can be sharper.

What the company highlighted in the FY25 March-quarter narrative

For background, the supplied PTI report said Syrma SGS reported consolidated net profit of ₹65.4 crore in the March quarter of FY25, up 87%, even as revenue from operations fell 18.4% to ₹924.3 crore. The company attributed the margin expansion to a shift away from low-margin consumer business toward higher value segments like industrial and healthcare. It was stated that industrial and healthcare together accounted for 50% of Q4 FY25 income. In the same narrative, management also indicated that the company was prioritising “value over volume,” which can compress revenue but support margins.

Additional operating metrics cited in the FY25 earnings call transcript

In the Q4 FY25 earnings call transcript excerpt provided, the company cited consolidated quarterly revenue of ₹947 crore and full-year export revenue of about ₹860 crore, around 23% of operating revenue. The same excerpt also cited operating EBITDA for the quarter of about ₹116 crore, with an operating EBITDA margin stated at 10.4% in one place and 12.4% in another portion of the transcript. The transcript also referenced net working capital days of around 69, a gross debt position of about ₹611 crore, a treasury balance of approximately ₹347 crore, and an operating cash flow of ₹170 crore for the year. It also mentioned incentives of about ₹35-36 crore booked for the full year FY25.

Snapshot of key numbers and estimates

Historical reference points mentioned in the provided data

Market impact: what investors in EMS will watch

The Electronics/EMS sector typically reacts to two things during result season: order visibility and margin durability. For Syrma SGS, Q4 FY26 will be read against the estimate band of ₹1,150-1,260 crore revenue and 6.5-7.5% EBITDA margin. If revenue growth aligns with the stated 15-20% year-on-year expectation, the next filter becomes whether PAT in the ₹38-48 crore range reflects operating improvement. Investors will also track any discussion of customer mix, export contribution, and the pace of shift away from lower-margin consumer business. Dividend commentary, especially with nil expected, will also be interpreted through the lens of free cash flow and working capital discipline.

Conclusion

Syrma SGS Technology’s Q4 FY26 results in May 2026 (expected) will be a key checkpoint for investors tracking execution in India’s EMS space. The immediate focus will be on how reported numbers compare with estimates for revenue, PAT and EBITDA margin, along with any final dividend decision. The next concrete step is the board meeting expected in May 2026 to approve the audited financials and consider the final dividend recommendation.